These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
464 related items for PubMed ID: 23369227
1. Serum irisin levels in new-onset type 2 diabetes. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, Lee WK, Kim JG, Lee IK, Park KG. Diabetes Res Clin Pract; 2013 Apr; 100(1):96-101. PubMed ID: 23369227 [Abstract] [Full Text] [Related]
2. Exenatide treatment increases serum irisin levels in patients with obesity and newly diagnosed type 2 diabetes. Liu J, Hu Y, Zhang H, Xu Y, Wang G. J Diabetes Complications; 2016 Apr; 30(8):1555-1559. PubMed ID: 27503404 [Abstract] [Full Text] [Related]
3. Irisin in the Glucose Continuum. Assyov Y, Gateva A, Tsakova A, Kamenov Z. Exp Clin Endocrinol Diabetes; 2016 Jan; 124(1):22-7. PubMed ID: 26479549 [Abstract] [Full Text] [Related]
4. Circulating serum irisin levels in obesity and type 2 diabetes mellitus. Shoukry A, Shalaby SM, El-Arabi Bdeer S, Mahmoud AA, Mousa MM, Khalifa A. IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658 [Abstract] [Full Text] [Related]
5. Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus. Elizondo-Montemayor L, Gonzalez-Gil AM, Tamez-Rivera O, Toledo-Salinas C, Peschard-Franco M, Rodríguez-Gutiérrez NA, Silva-Platas C, Garcia-Rivas G. Mediators Inflamm; 2019 Jul; 2019():6737318. PubMed ID: 31015797 [Abstract] [Full Text] [Related]
6. Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Atherosclerosis; 2014 Aug; 235(2):328-33. PubMed ID: 24911636 [Abstract] [Full Text] [Related]
7. The association of new inflammatory markers with type 2 diabetes mellitus and macrovascular complications: a preliminary study. Zhang M, Chen P, Chen S, Sun Q, Zeng QC, Chen JY, Liu YX, Cao XH, Ren M, Wang JK. Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1567-72. PubMed ID: 24943964 [Abstract] [Full Text] [Related]
8. Irisin levels in the progression of diabetes in sedentary women. Duran ID, Gülçelik NE, Ünal M, Topçuoğlu C, Sezer S, Tuna MM, Berker D, Güler S. Clin Biochem; 2015 Dec; 48(18):1268-72. PubMed ID: 26234637 [Abstract] [Full Text] [Related]
9. Association between irisin and homocysteine in euglycemic and diabetic subjects. Alis R, Sanchis-Gomar F, Pareja-Galeano H, Hernández-Mijares A, Romagnoli M, Víctor VM, Rocha M. Clin Biochem; 2014 Dec; 47(18):333-5. PubMed ID: 25192692 [Abstract] [Full Text] [Related]
10. The association between serum irisin levels and cardiovascular disease in diabetic patients. Khorasani ZM, Bagheri RK, Yaghoubi MA, Chobkar S, Aghaee MA, Abbaszadegan MR, Sahebkar A. Diabetes Metab Syndr; 2019 Dec; 13(1):786-790. PubMed ID: 30641808 [Abstract] [Full Text] [Related]
11. Lower circulating irisin is associated with type 2 diabetes mellitus. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, Ng XW, Tavintharan S, Sum CF, Lim SC. J Diabetes Complications; 2013 Dec; 27(4):365-9. PubMed ID: 23619195 [Abstract] [Full Text] [Related]
12. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study. Tang L, Tong Y, Zhang F, Chen G, Zhang YC, Jobin J, Tong N. BMC Endocr Disord; 2019 Dec 27; 19(1):147. PubMed ID: 31881940 [Abstract] [Full Text] [Related]
13. Irisin and leptin concentrations in relation to obesity, and developing type 2 diabetes: A cross sectional and a prospective case-control study nested in the Normative Aging Study. Sahin-Efe A, Upadhyay J, Ko BJ, Dincer F, Park KH, Migdal A, Vokonas P, Mantzoros C. Metabolism; 2018 Feb 27; 79():24-32. PubMed ID: 29108900 [Abstract] [Full Text] [Related]
14. Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents. Jang HB, Kim HJ, Kang JH, Park SI, Park KH, Lee HJ. Metabolism; 2017 Aug 27; 73():100-108. PubMed ID: 28732566 [Abstract] [Full Text] [Related]
15. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. Provatopoulou X, Georgiou GP, Kalogera E, Kalles V, Matiatou MA, Papapanagiotou I, Sagkriotis A, Zografos GC, Gounaris A. BMC Cancer; 2015 Nov 11; 15():898. PubMed ID: 26560078 [Abstract] [Full Text] [Related]
16. Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. Choi HY, Kim S, Park JW, Lee NS, Hwang SY, Huh JY, Hong HC, Yoo HJ, Baik SH, Youn BS, Mantzoros CS, Choi KM. J Clin Endocrinol Metab; 2014 Aug 11; 99(8):2778-85. PubMed ID: 24780049 [Abstract] [Full Text] [Related]
17. The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype. Hwang YC, Jeon WS, Park CY, Youn BS. Cardiovasc Diabetol; 2016 Jan 20; 15():9. PubMed ID: 26790404 [Abstract] [Full Text] [Related]
18. Novel adipokines vaspin and irisin as risk biomarkers for cardiovascular diseases in type 2 diabetes mellitus. El-Lebedy DH, Ibrahim AA, Ashmawy IO. Diabetes Metab Syndr; 2018 Sep 20; 12(5):643-648. PubMed ID: 29673927 [Abstract] [Full Text] [Related]
19. Plasma irisin is elevated in type 2 diabetes and is associated with increased E-selectin levels. Rana KS, Pararasa C, Afzal I, Nagel DA, Hill EJ, Bailey CJ, Griffiths HR, Kyrou I, Randeva HS, Bellary S, Brown JE. Cardiovasc Diabetol; 2017 Nov 09; 16(1):147. PubMed ID: 29121940 [Abstract] [Full Text] [Related]
20. The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans. Norheim F, Langleite TM, Hjorth M, Holen T, Kielland A, Stadheim HK, Gulseth HL, Birkeland KI, Jensen J, Drevon CA. FEBS J; 2014 Feb 09; 281(3):739-49. PubMed ID: 24237962 [Abstract] [Full Text] [Related] Page: [Next] [New Search]